Therapeutic Drug Monitoring

Breakthrough technology to enhance monoclonal antibody-based treatment

Labelled Etanercept  13C15N


Absolute quantification of Enbrel® or its biosimilars

Specific labelling

Arginine: 13C6,15N4, >99%

Lysine: 13C6,15N2, >99%

10 µg     ->    650 €      Quantity  

You must sign in or create an account to order this product


Etanercept is a chimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kilodalton (p75) tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. The Fc component of etanercept contains the CH2 domain, the CH3 domain and hinge region, but not the CH1 domain of IgG1. The product contains 10 µg recombinant Etanercept isotopically labeled (stable isotopes – non-radioactive) produced in HEK for in vitro research purpose and intended to be used as quantification standard in mass spectrometry analyses.This product is for research use only and is not intended for diagnostic or therapeutic use. PROMISE Advanced Proteomics shall not be held responsible for any damages resulting from the use of this product.